Urilin Syrup 100ml

Urilin syrup for dogs is used to manage urinary incontinence associated with urethral sphincter incompetence in neutered female dogs. It works by stimulating the receptors in the urethra sphincter muscle - causing them to tighten to reduce urine leakage.

Urilin is a syrup and a clear viscous solution. The active ingredient is 40mg/ml of Phenylpropanolamine per 100ml bottle. Shelf life of the veterinary medicinal product as packaged for sale: 3 years. Shelf life after first opening the immediate packaging: 3 months.

How To Buy Urilin Syrup

Urilin syrup is a prescription-only medication. This means that before you complete your purchase, you are required to upload a prescription through our online portal. After our team has confirmed you've ordered the right medication for your dog, we can send out your order. It's a simple process that means you can buy Urilinsyrup dog medication online instead of going to your vet every month.

How To Use Urilin Syrup

Urilin Syrup for dogs is for oral administration only. Care should be exercised in administering the product with other sympathomimetic drugs, anticholinergic drugs, tricyclic antidepressants or specific type B monoamine oxidase.

Used for the treatment of benign urinary incontinence, the following average doses are advised. However, the actual dose used should be determined by the severity of the signs and the length of time for which they have been present.

0.8 mg/kg body weight phenylpropanolamine (equivalent to 1 mg/kg phenylpropanolamine HCl) three times daily in the feed. This corresponds to 0.1 ml Urilin syrup per 5 kg body weight three times daily which equals 1 drop for every 2.34 kg body weight three times daily in feed.

Special Precautions

In some dogs, loose stools, liquid diarrhoea, a decrease in appetite, arrhythmia and collapse have been reported following treatment with phenylpropanolamine. Occasional nausea and vomiting have also been reported.

As phenylpropanolamine is a sympathomimetic agent it is possible to produce a wide range of effects most of which mimic the results of excess stimulation of the sympathetic nervous system (e.g. effects on the heart rate and blood pressure). Dizziness and restlessness were also occasionally reported. Hypersensitivity may occur in very rare cases.

Target species

Dogs (bitches).

Indications for use, specifying the target species

For the treatment of urinary incontinence associated with acquired urethral sphincter incompetence in the bitch only. The efficacy of phenylpropanolamine has only been demonstrated in ovariohysterectomised bitches.

Contraindications

Do not use in animals treated with non-selective monoamine oxidase inhibitors. Do not use in cases of known hypersensitivity to the active substance or to any of the excipients.

Special warnings for each target species

It is not appropriate to use the product for the behavioural cause of inappropriate urination.

Special precautions for use

Special precautions for use in animals

Because phenylpropanolamine is a sympathomimetic agent, it may affect the cardiovascular system, especially blood pressure and heart rate, and therefore should be used with caution in animals with cardiovascular diseases. Care should be exercised in treating animals with severe renal or hepatic insufficiency, diabetes mellitus, hyperadrenocorticism, glaucoma or other metabolic disorders.

In bitches less than 1 year old the possibility of anatomical disorders contributing to incontinence should be considered prior to treatment.

Special precautions for the person administering the veterinary medicinal product to animals

• People with known hypersensitivity to phenylpropanolamine should avoid contact with the veterinary medicinal product.
,li>Phenylpropanolamine hydrochloride is toxic when overdoses are ingested. Adverse effects may include dizziness, headache, nausea, insomnia or restlessness, and increased blood pressure. High overdose may be fatal, especially in children.
• To avoid accidental ingestion the product must be used and kept out of the sight and reach of children.
• Always replace the cap firmly after use to ensure that the child resistant closure operates correctly.
• In the event of accidental ingestion, seek immediate medical attention showing the doctor the package leaflet.
• Contact with eyes and skin should be avoided.
• In the event of accidental skin contact, wash the contaminated area with soap and water. Wash hands after use of the product.
• Redness and irritation may develop after eye or skin contact with the product.
• In the event of accidental eye contact, rinse the eye with clean water for about 15 minutes and seek medical advice.

Adverse reactions (frequency and seriousness)

In some dogs, loose stools, liquid diarrhoea, a decrease in appetite, arrhythmia and collapse have been reported following treatment with phenylpropanolamine. Occasional nausea and vomiting have also been reported. Treatment was continued depending on the severity of the undesirable effect observed.

As phenylpropanolamine is a sympathomimetic agent it is possible to produce a wide range of effects most of which mimic the results of excess stimulation of the sympathetic nervous system (e.g. effects on the heart rate and blood pressure). Dizziness and restlessness were also occasionally reported. Hypersensitivity may occur in very rare cases.

Use during pregnancy, lactation or lay

Do not use in pregnant or lactating bitches.

Interaction with other medicinal products and other forms of interaction

Care should be exercised in administering the product with other sympathomimetic drugs, anticholinergic drugs, tricyclic antidepressants or specific type B monoamine oxidase."